Food and Drug Regulations
C.03.208 Every kit shall be labelled to show
(a) its proper name;
(b) its brand name, if any;
(c) a list of its contents;
(d) the name and address of the distributor referred to in paragraph C.01A.003(b);
(e) the establishment licence number of the distributor preceded by the words “Establishment Licence Number”, “Numéro de licence d’établissement” or an abbreviation thereof;
(f) the lot number;
(g) a statement of any special storage requirements with respect to temperature and light;
(h) the date after which the kit is not recommended for use, the name of the month being written in full or designated by letter abbreviation;
(i) where the label of a component makes reference to the label of the kit that shows information as to the ingredients of the component, a quantitative list of the ingredients of that component;
(j) a statement of the sterility and apyrogenicity of the components;
(k) adequate directions for preparing the radiopharmaceutical or a reference to the accompanying package insert that shows such directions;
(l) a statement of the duration of the useful life of the prepared radiopharmaceutical;
(m) a statement of the storage requirements for the prepared radiopharmaceutical;
(n) a statement of the recommended use for the prepared radiopharmaceutical and the recommended radioactivity to be administered for that use, or a reference to the accompanying package insert that shows such information; and
(o) a statement of the route of administration of the prepared radiopharmaceutical.
(p) [Repealed, SOR/2001-203, s. 3]
- SOR/79-236, s. 4
- SOR/93-202, s. 18
- SOR/97-12, ss. 58, 62
- SOR/2001-203, s. 3
- SOR/2018-69, s. 36(F)
- Date modified: